ResultsIQ

ResultsIQ › Latest results › Tarsons Products Limited

Tarsons Products Limited Q4 FY25 earnings call summary

NSE: TARSONS · BSE: 543399

Earnings call of 29 May 2025, summarised by AI from the filing.

No formal guidance; expects similar CAGR growth in near future and exports to grow faster than domestic in FY26.

Key takeaways

  1. Guidance No formal guidance; expects similar CAGR growth in near future and exports to grow faster than domestic in FY26.
  2. Driver Early signs of recovery with rise in customer inquiries and RFQs; broader revival expected in H2 FY26.
  3. Risk Plastic labware industry has seen muted demand across key user segments for 6-8 quarters.

Original filing on BSE

Tarsons Products Limited Q1 FY27 results

As filed: Revenue ₹110 cr (+21% year on year), EBITDA ₹26.0 cr (+4% year on year), PAT −₹1.4 cr (−172% year on year), EBITDA margin 23.6% (−390 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹121 cr (+7% year on year), EBITDA ₹34.3 cr (−7% year on year), PAT ₹4.2 cr (−58% year on year), EBITDA margin 28.3% (−440 bps). Score 17 of 100, Below trend. Revenue growth was below the company's own trend; EBITDA and profit growth were well below it. EBITDA margin fell 440 bps year on year. Other income 115% of PBT. Profit fell 17% from last quarter. Share price after the results: +20.1% in 28 days (Nifty 500: +2.2%).
  • Q3 FY26: Revenue ₹108 cr (+12% year on year), EBITDA ₹31.5 cr (+9% year on year), PAT ₹5.0 cr (+11% year on year), EBITDA margin 29.2% (−98 bps). Score 37 of 100, Below trend. Revenue growth was in line with the company's own trend; EBITDA growth was below it; profit before exceptional items growth was above it. EBITDA margin fell 98 bps year on year. Other income 112% of PBT. Share price after the results: −8.1% in 28 days (Nifty 500: −4.0%).
  • Q2 FY26: Revenue ₹102 cr (+3% year on year), EBITDA ₹27.0 cr (+4% year on year), PAT ₹3.0 cr (−70% year on year), EBITDA margin 26.5% (+21 bps). Score 21 of 100, Below trend. EBITDA margin rose 21 bps year on year. Other income 100% of PBT. Not enough history for a trend yet: scored on growth alone. Share price after the results: −14.7% in 30 days (Nifty 500: +0.2%).
  • Q1 FY26: Revenue ₹91.0 cr (+7% year on year), EBITDA ₹25.0 cr (+39% year on year), PAT ₹2.0 cr (−50% year on year), EBITDA margin 27.5% (+630 bps). Score 42 of 100, In line with trend. EBITDA margin rose 630 bps year on year. Other income 100% of PBT. Not enough history for a trend yet: scored on growth alone. Revenue fell 19% from last quarter. Share price after the results: −15.6% in 30 days (Nifty 500: +2.1%).
  • Q4 FY25: Revenue ₹113 cr (+7% year on year), EBITDA ₹37.0 cr (+23% year on year), PAT ₹10.0 cr (0% year on year), EBITDA margin 32.7% (+444 bps). Score 53 of 100, In line with trend. EBITDA margin rose 444 bps year on year. Not enough history for a trend yet: scored on growth alone. Share price after the results: −10.6% in 30 days (Nifty 500: +3.5%).
  • Q3 FY25: Revenue ₹96.0 cr (+55% year on year), EBITDA ₹29.0 cr (+21% year on year), PAT ₹5.0 cr (−50% year on year), EBITDA margin 30.2% (−850 bps). Score 47 of 100, In line with trend. EBITDA margin fell 850 bps year on year. Tax rate 38%. Not enough history for a trend yet: scored on growth alone. Revenue fell 3% from last quarter.
  • Q2 FY25: Revenue ₹80.0 cr (+21% year on year), EBITDA ₹24.0 cr (−4% year on year), PAT ₹13.0 cr (0% year on year), EBITDA margin 30.0% (−788 bps). Score 31 of 100, Below trend. EBITDA margin fell 788 bps year on year. Other income 61% of PBT. Not enough history for a trend yet: scored on growth alone.

Past price moves after results do not indicate future moves. Not a recommendation.

Tarsons Products Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.